Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
By Ludwig Burger FRANKFURT (Reuters) – Novartis breast cancer drug Kisqali cut the risk of...
By Ludwig Burger FRANKFURT (Reuters) – Novartis breast cancer drug Kisqali cut the risk of...
By Dawn Chmielewski (Reuters) – Netflix Inc shareholders on Thursday withheld their support for the...
By Rajesh Kumar Singh CHICAGO (Reuters) – Southwest Airlines Co CEO Bob Jordan said on...
By Jonathan Stempel NEW YORK (Reuters) – Elon Musk is being accused of insider trading...
By David Morgan, Richard Cowan and Moira Warburton WASHINGTON (Reuters) – A divided U.S. House...
By Lucia Mutikani WASHINGTON (Reuters) – U.S. job openings unexpectedly rose in April and data...
By Brendan Pierson (Reuters) -Johnson & Johnson on Wednesday faced the first trial in almost...
By Moira Warburton and David Morgan WASHINGTON (Reuters) – Legislation brokered by President Joe Biden...
By Akash Sriram and Samrhitha A (Reuters) – Nvidia Corp briefly joined an elite club...
(Reuters) – Activist investor Legion Partners has met Twilio Inc officials several times, urging the...